Empashield-S 25/100 mg Tablet

Composition of Empashield-S 25/100 mg Tablet

Empashield-S 25/100 mg Tablet contains Empagliflozin 25 mg + Sitagliptin 100 mg tablet. It belongs to the SGLT2 inhibitor + DPP-4 inhibitor class of medicines.

Uses of Empashield-S 25/100 mg Tablet

• Treatment of type 2 diabetes mellitus to improve glycaemic control in adults
• as an add-on to diet and exercise when dual therapy is appropriate.

Key benefits

• Lowers HbA1c and fasting/post-meal glucose
• Low risk of hypoglycaemia when used without insulin/sulfonylurea
• Promotes mild weight loss
• May reduce blood pressure mildly
• Convenient once-daily combination therapy

How Empashield-S 25/100 mg Tablet works

Empagliflozin is an SGLT2 inhibitor that increases urinary glucose excretion by reducing glucose reabsorption in the kidneys. Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon secretion, thereby lowering blood glucose.

How to take Empashield-S 25/100 mg Tablet

Oral tablet. Take exactly as prescribed by the doctor, usually once daily; may be taken with or without food. Maintain adequate hydration; follow diet and exercise advice. Do not stop without medical advice.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause dehydration and a fall in blood pressure. It may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Empashield-S 25/100 mg Tablet

Most side effects of Empashield-S 25/100 mg are mild and settle as the body adjusts. Reported side effects include:

• Urinary tract infection
• genital fungal infection
• increased urination
• thirst
• dizziness
• headache
• nausea
• diarrhoea
• low blood sugar (especially with insulin/sulfonylurea)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Empashield-S 25/100 mg Tablet

Warnings and precautions

Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/low blood pressure—use caution in elderly, on diuretics, or with low fluid intake. Risk of genital mycotic infections and UTIs; seek care if pain/burning urination or fever occurs. Rare but serious: ketoacidosis (even with near-normal sugars), pancreatitis (severe abdominal pain), severe joint pain, hypersensitivity reactions. Monitor kidney function; not recommended in severe renal impairment/end-stage renal disease/dialysis. Temporarily stop before major surgery or during acute illness/fasting as advised by doctor.

Do not take Empashield-S 25/100 mg if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney disease.

Interactions with other medicines

Insulin and sulfonylureas (increased hypoglycaemia risk), diuretics (increased dehydration/hypotension), ACE inhibitors/ARBs and other antihypertensives (additive BP lowering), rifampicin (may reduce sitagliptin levels), digoxin (sitagliptin may increase digoxin levels), lithium (SGLT2 inhibitors may affect levels—monitor)

How to store Empashield-S 25/100 mg Tablet

Store below 25°C in a dry place. Protect from moisture and direct light. Keep out of reach of children.

Expert advice for Empashield-S 25/100 mg Tablet

Take it in the morning so the extra urine does not disturb your sleep. Keep up your fluid intake and maintain genital hygiene. Tell any doctor treating you for an acute illness that you take this medicine. It can be taken with or without food, at the same time each day. Keep up your diet and activity — this medicine supports them.

Manufacturer and class

Manufacturer:

LARENON

Therapeutic class:

Antidiabetic

Drug class:

SGLT2 inhibitor + DPP-4 inhibitor